Jiangsu Simcere Pharmaceutical Co., Ltd.

Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Neurology · Oncology · Psychiatry · Renal & urogenital · Respiratory · Women's health

Jiangsu Simcere Pharmaceutical Co., Ltd. is a clinical trial sponsor. It has 21 active clinical trials with 5,576 planned participants, across 14 therapeutic areas. Since 2021 it has completed 13 trials and stopped 5 early.

Trial track record · since 2021

21Active trials5,576 planned participants
13Completed1 with results posted
5Stopped early28% of finished trials

Pipeline · 21 active trials

StageTrialStatus

Questions about Jiangsu Simcere Pharmaceutical Co., Ltd

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-06.

Approve Suite is not affiliated with Jiangsu Simcere Pharmaceutical Co., Ltd..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.